{"id":"W2046284618","doi":"10.1586/era.09.42","title":"Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?","year":2009,"lang":"en","type":"letter","venue":"Expert Review of Anticancer Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gemcitabine; Bladder cancer; Cisplatin; Neoadjuvant therapy; Cystectomy; Oncology; Chemotherapy; Vinblastine; Regimen; Internal medicine; Urology; Doxorubicin; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009172793,0.0002501326,0.001267383,0.0003450419,0.0004653814,0.0007181612,0.0005754061,0.006190886,0.003345385],"category_scores_gemma":[0.007552568,0.0001709702,0.0006574813,0.000599771,0.0005482244,0.0009926817,0.0001867802,0.003501683,0.002844162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001433037,"about_ca_system_score_gemma":0.001000569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008566545,"about_ca_topic_score_gemma":0.002951928,"domain_scores_codex":[0.9995259,0.0001695653,0.00009731887,0.00004961373,0.0001073743,0.00005018292],"domain_scores_gemma":[0.998179,0.0009626,0.0001816381,0.00005649976,0.000419862,0.0002006157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001764782,0.0002530171,0.01579832,0.001069963,0.0001231977,0.01831704,0.0001442516,0.0003686376,0.002074559,0.002088507,0.5930245,0.3649732],"study_design_scores_gemma":[0.002889772,0.002327256,0.03971548,0.002786126,0.0005804434,0.07472453,0.000553335,0.001930809,0.002026469,0.01096018,0.8613727,0.0001329109],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01546454,0.05627344,0.0002547958,0.8970077,0.01424917,0.00005217608,0.0001672277,0.00004613667,0.01648485],"genre_scores_gemma":[0.1465705,0.07939,0.0009605572,0.6534843,0.1084896,0.0001354769,0.0002598331,0.00003605205,0.01067361],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.006190886,"threshold_uncertainty_score":0.01119137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01697129544645139,"score_gpt":0.3053958378885686,"score_spread":0.2884245424421172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}